Why Is ALIGNMENT HEALTHCARE (ALHC) Stock Down Today?

Alignment Healthcare (ALHC) shares fell 16.48% to $7.28 on Friday. The primary driver was a wave of analyst downgrades and price target cuts following a costly Medicare Advantage rating downgrade.

What Happened

BofA downgraded the stock to Neutral from Buy, while William Blair cut its rating to Market Perform citing cost pressures. KeyBanc lowered its price target to $12 from $28, and JPMorgan reduced its target to $10 from $22. These actions followed news that the company’s health insurance business faced a significant rating downgrade, impacting its outlook. The stock had been on a recent upward trend, rising 10.6% over the previous eight sessions from $7.88 to $8.71.

What The Data Shows

The stock opened at $6.75, a 22.5% gap down from the prior close of $8.71. Intraday trading saw a session low of $6.01 at 9:30 AM ET and a high of $7.36 at 9:45 AM ET. Volume reached 11.8 million shares, which is 1.6 times the three-month daily average. The company has a market cap of $1.8 billion and a P/E ratio of 44.1. Revenue grew 37.2% year-over-year, but the net margin is only 0.9%. The stock’s 52-week range is $7.37 to $25.12, and it printed fresh 52-week highs and lows on October 9, 2026. Recent insider activity shows nine sells totaling $23.3 million in the last 90 days, with no buys. CEO John E. Kao and other executives have also sold shares recently.

What To Watch

Investors should monitor the company’s response to the Medicare Advantage rating changes and any further analyst revisions. The recent insider selling and the sharp drop in valuation metrics suggest heightened scrutiny on the company’s cost management and future revenue sustainability.